"Where money issues meet IP rights". This weblog looks at financial issues for intellectual property rights: securitisation and collateral, IP valuation for acquisition and balance sheet purposes, tax and R&D breaks, film and product finance, calculating quantum of damages--anything that happens where IP meets money.
Showing posts with label pharmaceutical pricing. Show all posts
Showing posts with label pharmaceutical pricing. Show all posts
Monday, 26 February 2018
Wednesday, 11 January 2017